Strata Critical Medical, Inc. SRTA
5.33
0.06
1.14%
as of 25 Sep
- Market cap
- $476.8M
- P/E
- 10.5×
Follow SRTA
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 16.01% | 18.59% | 16.51% | 15.64% |
+8 more TTM periods Free account |
|
| 13.62% | 16.26% | 14.21% | 13.07% | ||
ROIC |
(4.98%) | (5.42%) | (6.42%) | (2.83%) | |
Return on Tangible Assets |
34.69% | 32.80% | 28.95% | 30.33% | |
Average Days of Receivables |
61.89 | 63.24 | 73.98 | 112.63 | |
Free Cash Flow per Share |
(0.57) | (0.68) | (0.73) | (0.68) | |
Free Cash Flow |
(49.52) | (58.13) | (59.92) | (56.40) | |
Capital Expenditures |
(13.48) | (13.34) | (11.01) | (14.04) | |
Piotroski F-Score |
4.00 | 4.00 | 4.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(11.92%) | (12.99%) | (14.36%) | (11.79%) | |
Accounts Receivable Turnover |
7.15 | 7.41 | 6.60 | 3.92 | |
Accounts Payable Turnover |
12.58 | 11.84 | 11.00 | 4.55 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
33.28 | 40.38 | 44.78 | 100.98 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 2.72% | |
Selling, General and Administrative Expense of Revenue |
25.34% | 28.06% | 30.88% | 26.48% | |
Share Based Compensation of Revenue |
6.64% | 8.16% | 9.05% | 12.97% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.90) | (0.95) | (1.18) | (1.05) | |
Depreciation/Fixed assets |
0.40 | 0.24 | 0.22 | 0.17 | |
Capex/Depreciation |
(0.83) | (1.40) | (1.35) | (2.09) | |
Revenue per Share |
2.97 | 2.68 | 2.40 | 1.48 | |
Operating CF per Share |
(0.42) | (0.52) | (0.60) | (0.51) | |
Capex per Share |
(0.16) | (0.16) | (0.13) | (0.17) | |
Capex to Sales |
0.05 | 0.06 | 0.06 | 0.12 | |
Net Profit Margin |
15.71% | 20.56% | 20.97% | 33.20% |
Columns are period end dates